Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
about
Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitorsTranslating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulatesCardiac matrix: a clue for future therapyMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisEpigenetic silencing of TIMP4 in heart failure.Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodelingTargeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in miceCardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.Diabetes influences cardiac extracellular matrix remodelling after myocardial infarction and subsequent development of cardiac dysfunction.ECM-Regulator timp Is Required for Stem Cell Niche Organization and Cyst Production in the Drosophila Ovary.MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarctionProtective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.Hypoxia inhibits cardiomyocyte proliferation in fetal rat hearts via upregulating TIMP-4Using the laws of thermodynamics to understand how matrix metalloproteinases coordinate the myocardial response to injuryNovel biomarkers in human terminal heart failure and under mechanical circulatory support.Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease.Targeting MMP-2 to treat ischemic heart injury.Cardiac Physiology of Aging: Extracellular Considerations.TIMPs: versatile extracellular regulators in cancer.Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.Beyond gut feelings: how the gut microbiota regulates blood pressure.Cardiac tissue inhibitor of matrix metalloprotease 4 dictates cardiomyocyte contractility and differentiation of embryonic stem cells into cardiomyocytes: Road to therapy.Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption.Identification of transcriptome signature for myocardial reductive stress.Dissecting the Role of the Extracellular Matrix in Heart Disease: Lessons from the Drosophila Genetic Model.Day-night dependence of gene expression and inflammatory responses in the remodeling murine heart post-myocardial infarction.The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.Expression and characterization of tissue inhibitor of metalloproteinase 4 from complex canine mammary carcinomas.Novel role of NADPH oxidase in ischemic myocardium: a study with Nox2 knockout mice.
P2860
Q26830555-CBA29006-5233-4D53-9129-DC8F75D7D3B6Q26865099-6B91CC95-3B54-40A5-B912-67CAD2471AEAQ27026864-AA411B70-695E-4283-8223-18BBC36D67C3Q28386047-8FB35354-9BE8-4140-A0CB-2F71271C7C09Q30371061-63E7E4B6-35FC-4DE3-B1A6-C83734A942D2Q33663388-D3DD6C15-A86B-4FB0-932E-5847814C882FQ33696289-C8FDD8F3-08A0-4EB6-B507-9220D7A62927Q34296764-0868CE37-2D71-4EC8-AF37-4D52DA4CCA60Q35370265-718DDD75-3A7E-4B27-A847-4BF8C44D2558Q35903664-7B7A8C9F-8642-4755-944B-13710D31D38FQ35951850-56F5282C-6D62-46F1-A31F-02B0C4D623A9Q36372517-5035637E-60EB-4E7C-B25A-580F7ABE8D2EQ36770762-5B116B3A-368C-4B70-B907-5C7CA312DB01Q37058562-6EFEDC4C-6E31-4A9A-82C8-5C266F9439ABQ37894731-732B71E0-EDF8-447B-80FD-6E323DE914F6Q37895982-D5FB273B-04C5-4983-BF57-7D716B5DC1F4Q38040163-7EDB2FCB-0FFA-44B9-980D-4F4A5FC9A9EEQ38225432-17737F4F-9589-4496-B05F-6E562A374D24Q38542448-EFDEE8AA-ED68-41B2-A0D6-E1A87EC4E3CAQ38785433-BB39502F-8375-49F1-B698-C6C5B3955A7CQ38963422-78202FCE-67C1-4450-BA2F-BA9F57EE660CQ40081529-B820B56F-78BD-4BC1-BDF0-40DE2F8825A2Q40185855-2946801E-E334-49C7-B83F-6B3A1EE8634DQ41108866-E42781BB-FB6E-4166-9734-8D600DFB5296Q41189456-8E088F57-88AA-4C7B-BF42-192E60B872B7Q43378616-27F8C918-892A-4084-B2D0-D82195DE23F1Q47807574-74BC6E74-3E3D-492C-994B-A5D169CDF487Q49375848-15837FB0-6090-4C5C-A9EB-8DED264C5F40Q53149264-CC50D7AE-9A44-4930-BE99-E98F242F3E92Q54341815-F842EE03-286B-4D7B-B09B-2881F87798AC
P2860
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Mice with tissue inhibitor of ...... to cardiac pressure overload.
@en
Mice with tissue inhibitor of metalloproteinases 4
@nl
type
label
Mice with tissue inhibitor of ...... to cardiac pressure overload.
@en
Mice with tissue inhibitor of metalloproteinases 4
@nl
prefLabel
Mice with tissue inhibitor of ...... to cardiac pressure overload.
@en
Mice with tissue inhibitor of metalloproteinases 4
@nl
P2093
P2860
P356
P1476
Mice with tissue inhibitor of ...... t to cardiac pressure overload
@en
P2093
Antti Saraste
Eero Jokinen
Eero Vuorio
Gavin Y Oudit
Ilpo Koskivirta
Otto Rahkonen
Peter P Liu
Riku Kiviranta
Ville Kytö
Zamaneh Kassiri
P2860
P304
24487-24493
P356
10.1074/JBC.M110.136820
P407
P577
2010-06-01T00:00:00Z